These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 10459911)

  • 21. Using antipsychotics in elderly patients.
    Livingston M; Livingston H
    Practitioner; 2002 Oct; 246(1639):657-8, 661-4, 666. PubMed ID: 12407950
    [No Abstract]   [Full Text] [Related]  

  • 22. Olanzapine: a new typical antipsychotic drug.
    Meltzer HY; Fibiger HC
    Neuropsychopharmacology; 1996 Feb; 14(2):83-5. PubMed ID: 8822530
    [No Abstract]   [Full Text] [Related]  

  • 23. Tardive dystonia: four case histories.
    Yadalam KG; Korn ML; Simpson GM
    J Clin Psychiatry; 1990 Jan; 51(1):17-20. PubMed ID: 1967246
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Importance of blood glucose level when starting antipsychotic treatment].
    Dervaux A; Mascarenhas N; Lambolez T
    Presse Med; 2001 Sep; 30(26):1298. PubMed ID: 11603092
    [No Abstract]   [Full Text] [Related]  

  • 25. Recurrence of neuroleptic malignant syndrome with olanzapine treatment.
    Gheorghiu S; Knobler HY; Drumer D
    Am J Psychiatry; 1999 Nov; 156(11):1836. PubMed ID: 10553758
    [No Abstract]   [Full Text] [Related]  

  • 26. New-onset tardive dyskinesia in patients with first-episode psychosis receiving risperidone or haloperidol.
    Gharabawi GM; Bossie CA; Zhu Y
    Am J Psychiatry; 2006 May; 163(5):938-9. PubMed ID: 16648343
    [No Abstract]   [Full Text] [Related]  

  • 27. Blonanserin improved dystonia induced by risperidone or olanzapine in two patients with schizophrenia.
    Takaki M; Mizuki Y; Miki T
    J Neuropsychiatry Clin Neurosci; 2014 Apr; 26(2):E14. PubMed ID: 24763772
    [No Abstract]   [Full Text] [Related]  

  • 28. Marked improvement of tardive dystonia after replacing haloperidol with risperidone in a schizophrenic patient.
    Yoshida K; Higuchi H; Hishikawa Y
    Clin Neuropharmacol; 1998; 21(1):68-9. PubMed ID: 9579290
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Review of recent clinical studies with olanzapine.
    Tollefson GD; Kuntz AJ
    Br J Psychiatry Suppl; 1999; (37):30-5. PubMed ID: 10211139
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Olanzapine-induced mania.
    Reeves RR; McBride WA; Brannon GE
    J Am Osteopath Assoc; 1998 Oct; 98(10):549-50. PubMed ID: 9821737
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pulmonary embolism possibly associated with olanzapine treatment.
    Waage IM; Gedde-Dahl A
    BMJ; 2003 Dec; 327(7428):1384. PubMed ID: 14670884
    [No Abstract]   [Full Text] [Related]  

  • 32. Management of a risperidone-induced tardive Pisa syndrome: a case report.
    Kaufmann A; Boesch S; Fleischhacker WW; Hofer A
    J Clin Psychopharmacol; 2012 Jun; 32(3):418-20. PubMed ID: 22561474
    [No Abstract]   [Full Text] [Related]  

  • 33. [Oculogyric crisis as an isolated extrapyramidal symptom of auto-intoxication with risperidone].
    van Renterghem L; Titeca K; Crunelle CL; Geerts P; Matthys F
    Tijdschr Psychiatr; 2019; 61(9):649-653. PubMed ID: 31560785
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of olanzapine in hereditary coproporphyria.
    Strauss J; DiMartini A
    Psychosomatics; 1999; 40(5):444-5. PubMed ID: 10479951
    [No Abstract]   [Full Text] [Related]  

  • 35. Olanzapine: a novel atypical neuroleptic agent.
    Reus VI
    Lancet; 1997 May; 349(9061):1264-5. PubMed ID: 9142055
    [No Abstract]   [Full Text] [Related]  

  • 36. Risperidone and tardive dyskinesia: a case report.
    Addington DE; Toews JA; Addington JM
    J Clin Psychiatry; 1995 Oct; 56(10):484-5. PubMed ID: 7559377
    [No Abstract]   [Full Text] [Related]  

  • 37. Paranoia and agitation associated with olanzapine treatment.
    al Jeshi A
    Can J Psychiatry; 1998 Mar; 43(2):195. PubMed ID: 9533976
    [No Abstract]   [Full Text] [Related]  

  • 38. Psychosis of Alzheimer disease.
    Snowdon J
    Am J Geriatr Psychiatry; 2006 Mar; 14(3):293-4. PubMed ID: 16505135
    [No Abstract]   [Full Text] [Related]  

  • 39. An Unexpected Circumstance: Acute Dystonic Reaction in the Setting of Clozapine Administration.
    Kaplan AM; Pitts WB; Ahmed I
    J Pharm Pract; 2019 Feb; 32(1):103-105. PubMed ID: 29092658
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Attention deficit-hyperactivity disorder may be a risk factor for treatment-emergent tardive dyskinesia induced by risperidone.
    Silver H; Aharon N; Schwartz M
    J Clin Psychopharmacol; 2000 Feb; 20(1):112-4. PubMed ID: 10653224
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.